These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2058671)

  • 1. Abnormal gallbladder motility in irritable bowel syndrome: evidence for target-organ defect.
    Kamath PS; Gaisano HY; Phillips SF; Miller LJ; Charboneau JW; Brown ML; Zinsmeister AR
    Am J Physiol; 1991 Jun; 260(6 Pt 1):G815-9. PubMed ID: 2058671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered sensitivity of the gallbladder to cholecystokinin octapeptide in irritable bowel syndrome.
    Kellow JE; Miller LJ; Phillips SF; Zinsmeister AR; Charboneau JW
    Am J Physiol; 1987 Nov; 253(5 Pt 1):G650-5. PubMed ID: 3318495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea.
    Chey WY; Jin HO; Lee MH; Sun SW; Lee KY
    Am J Gastroenterol; 2001 May; 96(5):1499-506. PubMed ID: 11374689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct contractile response of isolated gallbladder smooth muscle cells to cholecystokinin in patients with gallstones.
    Chijiiwa K; Yamasaki T; Chijiiwa Y
    J Surg Res; 1994 May; 56(5):434-8. PubMed ID: 8170143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin inhibits cholecystokinin-induced contraction of isolated gallbladder smooth muscle cells.
    Yamasaki T; Chijiiwa K; Chijiiwa Y
    J Surg Res; 1995 Dec; 59(6):743-6. PubMed ID: 8538175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A study of the dynamics of gallbladder contraction in irritable bowel syndrome].
    Kanazawa F; Mine K; Mishima N; Muraoka M; Nakagawa T
    Nihon Shokakibyo Gakkai Zasshi; 1992 Apr; 89(4):1185-90. PubMed ID: 1593776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different pathways mediate cholecystokinin actions in cholelithiasis.
    Chen Q; De Petris G; Yu P; Amaral J; Biancani P; Behar J
    Am J Physiol; 1997 Apr; 272(4 Pt 1):G838-44. PubMed ID: 9142916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal gallbladder function in patients with irritable bowel syndrome.
    Sood GK; Baijal SS; Lahoti D; Broor SL
    Am J Gastroenterol; 1993 Sep; 88(9):1387-90. PubMed ID: 8362836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysmotility of the small intestine in irritable bowel syndrome.
    Kellow JE; Phillips SF; Miller LJ; Zinsmeister AR
    Gut; 1988 Sep; 29(9):1236-43. PubMed ID: 3197998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenergic-serotonergic influences on gallbladder motility and irritable bowel syndrome.
    Lechin F
    Am J Physiol; 1992 Feb; 262(2 Pt 1):G375-6. PubMed ID: 1539672
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro responses of gallbladder muscle from patients with acalculous biliary pain.
    Ahmed R; Bird NC; Chess-Williams R; Thomas WE; Johnson AG
    Digestion; 2000; 61(2):140-4. PubMed ID: 10705179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro effects of cholecystokinin fragments on human gallbladders. Evidence for an altered CCK-receptor structure in a subgroup of patients with gallstones.
    Schneider H; Sänger P; Hanisch E
    J Hepatol; 1997 May; 26(5):1063-8. PubMed ID: 9186837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct receptors for cholecystokinin and gastrin on muscle cells of stomach and gallbladder.
    Grider JR; Makhlouf GM
    Am J Physiol; 1990 Aug; 259(2 Pt 1):G184-90. PubMed ID: 2382717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cholecystokinin-octapeptide on the human gallbladder both in vivo and in vitro.
    Takahashi T; Yamamura T; Ishikawa Y; Kantoh M; Utsunomiya J
    Gastroenterol Jpn; 1986 Feb; 21(1):49-54. PubMed ID: 3516785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Functional abnormality of the digestive tract and the gall bladder in irritable bowel syndrome].
    Takahashi T
    Nihon Rinsho; 1992 Nov; 50(11):2691-6. PubMed ID: 1287244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gallbladder contractility in children with functional abdominal pain or irritable bowel syndrome].
    Iwańczak F; Siedlecka-Dawidko J; Iwanczak B
    Pol Merkur Lekarski; 2013 Jul; 35(205):14-7. PubMed ID: 23984599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil-derived oxidants modify CCK-OP-stimulated guinea pig gallbladder contraction in vitro.
    Moummi C; Gullikson GW; Grisham MB; Gaginella TS
    Am J Physiol; 1991 Apr; 260(4 Pt 1):G571-6. PubMed ID: 1850205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of cholecystokinin receptors on the human gallbladder.
    Tokunaga Y; Cox KL; Coleman R; Concepcion W; Nakazato P; Esquivel CO
    Surgery; 1993 Feb; 113(2):155-62. PubMed ID: 7679224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gallbladder dynamics in patients with irritable bowel syndrome and essential dyspepsia.
    Misra SP; Dwivedi M; Mital M; Misra V
    J Clin Gastroenterol; 1991 Feb; 13(1):65-8. PubMed ID: 2007748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of gallbladder motility in patients with irritable bowel syndrome.
    Guliter S; Yilmaz S; Yakaryilmaz F; Keles H
    Swiss Med Wkly; 2005 Jul; 135(27-28):407-11. PubMed ID: 16220411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.